Lee Ainslie - Maverick Capital Ltd
Holding/activity history for Boston Scientific (BSX)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 4,195,089 | 3.06 | Add 42.48% | 0.91 | $62.75 | $263,241,835 | SEC |
| 2025 Q4 | 2,944,254 | 3.02 | Buy | 3.02 | $95.35 | $280,734,619 | SEC |
| 2024 Q2 | 0 | 0.00 | Sell 100.00% | 0.01 | SEC | ||
| 2024 Q1 | 5,748 | 0.01 | Reduce 34.91% | <0.01 | $68.49 | $393,681 | SEC |
| 2023 Q4 | 8,831 | 0.01 | Buy | 0.01 | $57.81 | $510,520 | SEC |
| 2021 Q4 | 0 | 0.00 | Sell 100.00% | 0.03 | SEC | ||
| 2021 Q3 | 62,528 | 0.03 | Reduce 34.32% | 0.01 | $43.39 | $2,713,000 | SEC |
| 2021 Q2 | 95,196 | 0.04 | Add 187.38% | 0.03 | $42.76 | $4,071,000 | SEC |
| 2021 Q1 | 33,126 | 0.01 | Reduce 52.70% | 0.02 | $38.64 | $1,280,000 | SEC |
| 2020 Q4 | 70,041 | 0.04 | Add 8.94% | <0.01 | $35.95 | $2,518,000 | SEC |
| 2020 Q3 | 64,296 | 0.05 | Buy | 0.05 | $38.21 | $2,457,000 | SEC |
| 2019 Q1 | 0 | 0.00 | Sell 100.00% | 0.04 | SEC | ||
| 2018 Q4 | 77,730 | 0.04 | Buy | 0.04 | $35.34 | $2,747,000 | SEC |
| 2018 Q2 | 0 | 0.00 | Sell 100.00% | 0.03 | SEC | ||
| 2018 Q1 | 71,740 | 0.03 | Buy | 0.03 | $27.32 | $1,960,000 | SEC |
| 2006 Q4 | 0 | 0.00 | Sell 100.00% | 1.34 | SEC | ||
| 2006 Q3 | 6,615,200 | 1.34 | Reduce 60.72% | 2.36 | $14.79 | $97,839,000 | SEC |
| 2006 Q2 | 16,839,200 | 3.88 | Add 45.41% | 1.21 | $16.84 | $283,572,000 | SEC |
| 2006 Q1 | 11,580,200 | 3.91 | Buy | 3.91 | $23.05 | $266,924,000 | SEC |